Albena Jordanova
scientist
neurology
Flanders Interuniversity Institute for Biotechnology
Belgium
Biography
MSc in Biochemistry and Microbiology, Sofia University, “St. Kliment Ohridski”, 1992 PhD in Molecular Genetics, Sofia Medical University, 1999 Board Certification in Medical Biology, Sofia Medical University, 2001 Associate Professor in Molecular Neurosciences, University of Antwerp, since 2007 Associate Professor in Human Molecular Genetics,: Sofia Medical University, since 2009 VIB Group Leader since 2011
Research Interest
Neuroscience
Publications
-
CMT-associated mutations in glycyl- and tyrosyl-tRNA synthetases exhibit similar pattern of toxicity and share common genetic modifiers in Drosophila Ermanoska B, Motley W, Gonçalves R, Asselbergh B, Lee L, De Rijk P, Sleegers K, Ooms T, Godenschwege T, Timmerman V, Fischbeck K, Jordanova ANEUROBIOLOGY OF DISEASE, 68, 180-9, 2014
-
CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase He W* Bai G* Zhou H Wei N White N Lauer J Liu H Shi Y Dumitru C Lettieri K Shubayev V Jordanova A Guergueltcheva V Griffin P Burgess R Pfaff S Yang XNATURE, 526, 710-4, 2015* These authors contributed equally
-
Charcot-Marie-Tooth disease type 2G redefined by a novel mutation in LRSAM1 Peeters K, Palaima P, Pelayo-Negro A, Garcia A, Gallardo E, Garcia-Barredo R, Mateiu L, Baets J, Menten B, De Vriendt E, De Jonghe P, Timmerman V, Infante J, Berciano J, Jordanova AANNALS OF NEUROLOGY, 80, 823-833, 2016
